CAMPBELL DAVID ALAN (Chief Executive Officer) reported 1 transaction at JANUX THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/1/2026ACC: 0001864158-26-000006
DirectorOfficer· Chief Executive Officer
Since Jun 2021
-123.84K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
123.84K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−123.84K
Price / share
—
Trade value
—
% of position
31.9%
7/31/2026
388.58K→264.74K
Total
Net shares
−123.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2026 | G · Gift | −123.84K | — | — | 31.9% | 388.58K | 264.74K |
| Total | −123.84K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported